Business NewsVideosMylan CEO Faces Calls to Explain 400% EpiPen Increase
ADVERTISEMENT

Mylan CEO Faces Calls to Explain 400% EpiPen Increase

19 Mar 2017, 10:06 AM IST i
NDTV Profit
NDTV Profit
Aug. 24 -- Members of Congress are in an unusual position as they demand an explanation for Mylan NV’s 400 percent price hike for the EpiPen and focus attention squarely on its CEO: Heather Bresch. Bloomberg's Toluse Olorunnipa reports on "Bloomberg Markets."
PVR INOX's Executive Director On Pricing Strategy, Occupation Trends And Dhurandhar Impact
PVR INOX's Executive Director On Pricing Strategy, Occupation Trends And Dhurandhar Impact
Jan 08, 2026
KSH International MD And CFO Talk Financials, Key Drivers Of Growth
KSH International MD And CFO Talk Financials, Key Drivers Of Growth
Jan 07, 2026
NDTV Indian of the Year 2025: Group Captain Shubhanshu Shukla Bags Science Icon Of The Year Award
NDTV Indian of the Year 2025: Group Captain Shubhanshu Shukla Bags Science Icon Of The Year Award
Jan 05, 2026
View All